These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1296493)

  • 1. [Clinical tolerability of ioversol 300 in brain computed tomography].
    Gillard C; Tatu L; Menegazzo D; Bonneville JF
    Ann Radiol (Paris); 1992; 35(4 Pt 2):284-7. PubMed ID: 1296493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of efficacy and tolerability of ioversol in intravenous urography].
    Lemaître L
    Ann Radiol (Paris); 1992; 35(4 Pt 2):303-6. PubMed ID: 1296497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of diagnostic efficacy and clinical tolerability of ioversol in "whole body" computed tomography in children. A non comparative phase III trial].
    Panuel M; Devred P; Faure F; Bourlière-Najean B; Ternier F; Le Bail C
    Ann Radiol (Paris); 1992; 35(4 Pt 2):280-3. PubMed ID: 1296492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparative study on the contrast quality, tolerance and safety of ioversol 300 versus iohexol 300 in central venous angiography (C.V. DSA).
    Rieser R; Beinborn W; Ney N
    Ann Radiol (Paris); 1992; 35(4 Pt 2):311-4. PubMed ID: 1296499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ionic versus nonionic contrast media: a prospective study of the effect of rapid bolus injection on nausea and anaphylactoid reactions.
    Federle MP; Willis LL; Swanson DP
    J Comput Assist Tomogr; 1998; 22(3):341-5. PubMed ID: 9606371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary European intravenous clinical experience with a new, low osmolar, nonionic contrast medium: ioversol (Optiray).
    Le Mignon MM; Azau C; Arthaud A; Bonnemain B
    Eur J Radiol; 1991; 13(2):126-33. PubMed ID: 1743190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacotoxicological profile of a non-ionic LOCM at high hydrophilicity: ioversol].
    Doucet D; Idée JM
    Ann Radiol (Paris); 1992; 35(4 Pt 2):267-72. PubMed ID: 1296489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An observational study to evaluate the efficiency and safety of ioversol pre-filled syringes compared with ioversol bottles in contrast-enhanced examinations.
    Vogl TJ; Wessling J; Buerke B
    Acta Radiol; 2012 Oct; 53(8):914-20. PubMed ID: 22983259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the low-osmolality contrast medium ioversol (Optiray) on renal function in a geriatric population.
    Louvel JP; Primard E; Henry J; Houlette C; Weinstein A; Janvresse A
    Acta Radiol; 1996 Nov; 37(6):950-3. PubMed ID: 8995472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ioversol in intravenous excretory urography. Evaluation of radiographic quality, patient tolerance and safety in four clinical studies.
    Jahn H; Müller-Späth R
    Ann Radiol (Paris); 1992; 35(4 Pt 2):297-302. PubMed ID: 1296496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of efficacy and tolerability of ioversol in intravenous urography. A comparative double-blind study versus iopamidol].
    Joffre F; Rousseau H; Aziza R
    Ann Radiol (Paris); 1992; 35(4 Pt 2):288-92. PubMed ID: 1296494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the concentration of contrast medium in dynamic computed tomography of the neck: consequences for image quality, side effects and cost.
    Wang R; Birchall IW; Hanson J
    Can Assoc Radiol J; 1995 Feb; 46(1):27-31. PubMed ID: 7834482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spiral CT angiography of the abdominal aorta. Comparison of iodixanol and ioversol.
    Fischbach R; Landwehr P; Svaland M; Pape HG; Brochhagen HG; Kampenes VB; Heindel W; Lackner K
    Invest Radiol; 1999 May; 34(5):374-80. PubMed ID: 10226851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Double-blind randomized study comparing ioversol 300 versus iopromide 300 abdominal computed tomography (CT scanner)].
    Hoogewoud HM; Neiss AC; Woessmer B
    Ann Radiol (Paris); 1992; 35(4 Pt 2):273-5. PubMed ID: 1296490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ioversol 350: clinical experience in skull x-ray computed tomography].
    Théron J; Paugam JP; Courthéoux P
    Ann Radiol (Paris); 1991; 34(6-7):413-7. PubMed ID: 1822666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous contrast agents and associated changes in serum osmolality.
    George M; Shannon M
    Pediatr Emerg Care; 2009 Sep; 25(9):555-7. PubMed ID: 19755886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ioversol 320: a new nonionic, water-soluble contrast medium for body computed tomography clinical trial.
    Kopecky KK; Becker GJ; Conces DJ
    Invest Radiol; 1989 Jun; 24 Suppl 1():S33-4. PubMed ID: 2687192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ioversol 300 and iopamidol 300 in "whole body" computed tomography. A double-blind clinical trial].
    Chagnaud C; Moulin G; Delannoy L; Gaubert JY; Haddad D; Bartoli JM; Kasbarian M
    Ann Radiol (Paris); 1992; 35(4 Pt 2):276-9. PubMed ID: 1296491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous excretory urography using Optiray in office urology.
    Koncz PM
    Int Urol Nephrol; 1995; 27(3):257-60. PubMed ID: 7591587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of low-osmolality contrast media for cranial CT: a dose comparison of two contrast agents.
    Kuhn MJ; Baker MR
    AJNR Am J Neuroradiol; 1990; 11(5):847-9; discussion 850-1. PubMed ID: 2120986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.